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Dogs with epilepsy are among the commonest neurological patients in veterinary practice and therefore have
historically attracted much attention with regard to definitions, clinical approach and management. A number of
classification proposals for canine epilepsy have been published during the years reflecting always in parts the
current proposals coming from the human epilepsy organisation the International League Against Epilepsy (ILAE).
It has however not been possible to gain agreed consensus, “a common language”, for the classification and
terminology used between veterinary and human neurologists and neuroscientists, practitioners, neuropharmacologists
and neuropathologists. This has led to an unfortunate situation where different veterinary publications and textbook
chapters on epilepsy merely reflect individual author preferences with respect to terminology, which can be confusing
to the readers and influence the definition and diagnosis of epilepsy in first line practice and research studies.
In this document the International Veterinary Epilepsy Task Force (IVETF) discusses current understanding of canine
epilepsy and presents our 2015 proposal for terminology and classification of epilepsy and epileptic seizures. We
propose a classification system which reflects new thoughts from the human ILAE but also roots in former well
accepted terminology. We think that this classification system can be used by all stakeholders.
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Epilepsy is a complex brain disease where sudden and
abnormal activity in neuronal networks causes the
prominent clinical sign of seizures characterised by
motor, autonomic and/or behavioural features. Epileptic
seizures are episodic and brief (in most cases less than
2–3 min). Epilepsy can rise from a plethora of causes. A
few rare cases are purely genetic (e.g. channelopathies),
some are developmental and have complex genetic and
epigenetic influences (e.g. neuronal migration disorders)
and some are caused by injury to the brain (e.g. trauma,
infectious, inflammatory, vascular or neoplastic disease).* Correspondence: mbe@sund.ku.dk
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creativecommons.org/publicdomain/zero/1.0/In a significant number of cases, the cause is not clear. Al-
though the mechanisms behind companion animal epi-
lepsy are largely uncovered, it is clear that epilepsy in
some purebred dogs is a direct result of a genetic defect,
where seizures are the core clinical sign of disease. This
has been described for the Lagotto Romagnolo, Belgian
shepherd and Boerboels [1–4]. A high epilepsy prevalence
in a specific breed or the accumulation of epileptic indi-
viduals within specific dog families are strong indicators of
inherited epilepsy, but often it is unknown if genetic de-
fects are the sole cause of the epilepsy or if the epilepsy
might arise from multifactorial causal influences including
environmental, developmental, provoking and genetic fac-
tors, and similar issues apply to human cases [5].
The true prevalence of epilepsy in dogs is unknown
and has been estimated to be 0.6–0.75 % in the generalarticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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lence studies in specific breeds with idiopathic epilepsy
has been conducted in the Labrador retriever (3.1 %),
Belgian shepherd (9.4 %) and petit Basset Griffon vend-
een (8.9 %), and pedigree studies in the Boxer, Irish
wolfhound, English Springer spaniel, Vizsla, Bernese
mountain dog, Standard poodle, Belgian shepherd,
Border collie, Australian shepherd and Border terrier
among others, and these have provided evidence for inher-
ited epilepsy [8–25] (for further information on epilepsy
related to specific breeds see Hülsmeyer et al. [26]). Given
the heterogeneity of epilepsy where causes and signs of
disease are greatly variable, a standardised terminology
and classification system for epilepsy is crucial in order to
provide accurate descriptive information for diagnostic
and communicative processes.
Since 1964 epilepsy and epileptic seizures have in hu-
man medicine been organized and categorized in a clas-
sification and terminology system, published by the
International League Against Epilepsy—ILAE [27–33].
The ILAE sees itself as “the world's preeminent associ-
ation of physicians and other health professionals work-
ing towards a world where no persons’ life is limited by
epilepsy” and the noble mission of this organization is
“to ensure that health professionals, patients and their
care providers, governments, and the public world-wide
have the educational and research resources that are es-
sential in understanding, diagnosing and treating persons
with epilepsy” (ILAE homepage www.ilae.org).
The 1985 classification of seizure types and the 1989
classification of the epilepsies continues to be used world-
wide in human epilepsy [32, 34]. However, in recent years,
the ILAE classification task force has taken to continually
updating and revising on the subject of epilepsy producing
new consensus documents approximately every 5 years
with the most recent being published in 2010 and a further
version is currently under much debate [27]. The termin-
ology and classification framework they provide is seen as
an ever evolving process, reflecting the constant gain in
our understanding of the disease and the complications in-
herent in ambiguous, misinterpreted and potentially stig-
matising vocabulary. This has generated considerable
discussion amongst their members reflecting the complex-
ity of the task.
In veterinary medicine, a number of classification pro-
posals for canine epilepsy have been published over the
years always reflecting in part the current ILAE pro-
posals (e.g. [35–38]). There remains, however, a lack of a
consensus, a common ‘language’, for the classification
and terminology used between veterinary and human
neurologists and neuroscientists, practitioners, neuro-
pharmacologists and neuropathologists. Companion ani-
mal epilepsy papers reflect a variety of modifications of
the definitions of epilepsy and epileptic seizures derivedfrom the core classification documents of the ILAE (e.g.
[1, 7, 9–15, 17, 23–25, 27, 28, 30–36, 38–46]. This has
led to an unfortunate situation where different veterin-
ary publications and textbook chapters on epilepsy
merely reflect individual author preferences with respect
to terminology, which can be confusing for the reader.
Put in a scientific and educational perspective, the exist-
ing lack of uniformity with respect to definitions and
terminology furthermore represents a major problem, as
comparisons between research studies are compro-
mised. Even more important, it prevents the implemen-
tation of a common understanding of epilepsy and
standardized professional guidelines which can help cli-
nicians when diagnosing animals with epilepsy and ad-
vising the owners.
Terminology and classification of epilepsy should be a
‘user friendly’, reliable and valid tool for the benefit of
different users and the patient [47]. There is a ‘chain of
care’ from the pet’s owner through the primary clinician
to neurology specialists and researchers. The language
should be concise to reduce errors and to simplify con-
versation. The first opinion veterinarian and specialists
alike should be able to use the classification framework
to manage the disease appropriately and to communi-
cate with others using the same language. In the age of
the internet, the pet owner also needs to be able to, at
least in part, comprehend the terminology used. The sci-
entist should find in the classification a pragmatic and
reliable instrument to investigate the disease’s aetiology,
pathophysiology, treatment, and outcome. Finally ter-
minology should reflect current knowledge and not be
changed for the sake of change, which has recently also
been emphasized by Shorvon (2014) [5] and others with
respect to the ILAE discussions on classification. Other-
wise important historical data might be lost and in some
cases it might be wise to stay with terms which are in
widespread use and have stood a test of time instead of
a rapid change of terminology emanating from academic
discussions [5]. Considering these issues, terminology
and classification needs to fulfil dissimilar and some-
times antagonistic needs and at the same time be adapt-
able to change.
In adopting the terms associated with human epilepsy
we should acknowledge some of the very significant dif-
ferences when applying it to small animal patients. We
cannot interview our patients as in human medicine and
the clinician’s interpretation of the patient’s seizure signs
are invariably restricted to the owner's description and
often a poor quality video(s). Typically electroencephal-
ography (EEG) is an impractical tool in animals and so
cannot contribute to a general classification scheme—in
contrast to the situation in human medicine. Further-
more some owners will decline diagnostic investigation
due to financial concerns or because some procedures
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report of seizure history and phenomenology, supported
by digital (video) recordings, remain the most central
diagnostic epilepsy marker in companion animals (in
fact as it does in humans).
Another discrepancy between people and animals which
must be addressed is the assessment of possible impair-
ment of consciousness during seizures. The determination
of consciousness impairment is challenging and often very
important to people because of personal and public safety.
The ILAE classification cites consciousness as an import-
ant factor for diagnosis. Veterinary medicine is better
aligned with the challenges facing paediatric medicine in
this regard.
This consensus statement group aims to provide the
veterinary community with a proposal focused on the
classification of epilepsy and epileptic seizures. To en-
sure we have all stakeholders involved, the consensus-
working group is composed of veterinary and human
neurologists and neuroscientists, practitioners, neuro-
pharmacologists and neuropathologists.
Proposal
In recent years the ILAE has been able to advance hu-
man epilepsy classification to a sophisticated level as a
consequence of advanced diagnostics and the uncovering
of an increasing number of mechanisms (including gen-
etic) that lead to epilepsy. The definition of epilepsy ac-
cepted by the ILAE in 2005 reflected the immense
progress with respect to the identification of aetiologies
and the understanding of seizure generation. Here an
epileptic seizure was defined as: “A transient occurrence
of signs and/or symptoms due to abnormal excessive or
synchronous neuronal activity in the brain”, and epilepsy
was defined as: “A disorder of the brain characterized by
an enduring predisposition to generate epileptic seizures
and by the neurobiologic, cognitive, psychological, and so-
cial consequences of this condition. The definition of epi-
lepsy requires the occurrence of at least one epileptic
seizure” [30]. In 2010 the ILAE refined the definitions
even further [27]; to demonstrate the on-going discus-
sions in the ILAE, it has recently been proposed that
epilepsy should be considered a true disease of the brain
[48]. This contradicts the previous understanding of epi-
lepsy as a condition of the brain—or a collection of signs
from the brain. Berg and Scheffer stated back in 2011
[28]: “These proposals are not meant to be permanent,
but form part of a transition to a system that will ultim-
ately allow for meaningful translation of scientific under-
standing to the classification of the epilepsies for clinical
and other purposes”. Although we need to move veterin-
ary epilepsy classification forward we also must, as in
human medicine, consider carefully whether any change
of terminology is meaningful [5]; we must accept thatcurrently we have not advanced the scientific under-
standing of the mechanisms leading to epilepsy in com-
panion animals to the level applicable to the ILAE.
In the following sections the IVETF discusses the
current understanding of companion animal epilepsy and
presents our 2015 proposal for terminology and classifica-
tion of epilepsy and epileptic seizures. We propose a clas-
sification system which reflects new thoughts from the
human ILAE but also has its roots in former well accepted
terminology. We think that this classification system can
be used by all stakeholders. The classification has two ele-
ments: (a) an aetiological element and (b) a seizure type
classification.Definitions
In human medicine, epilepsy can often be confirmed
by electroencephalography (EEG) although epileptic
people may have a normal EEG and an abnormal EEG
can also exist in people without epilepsy. The use of
EEG in veterinary medicine is currently of questionable
routine clinical value and therefore our definitions
should be seen as clinically operational and reflecting
expert knowledge in the field with respect to the typ-
ical appearance of epileptic seizures and their symp-
tomatology. This is not a major drawback, and for
definition purposes, it is reasonable (in human and ani-
mal epilepsy) to define seizures and epilepsy by the
clinical appearance of seizures. Please also refer to the
glossary for further definitions not listed in the main
text.Seizure
The term can be used for any sudden, short lasting and
transient event. It does not imply that the event is
epileptic.Epileptic seizure
Manifestation(s) of excessive synchronous, usually self-
limiting epileptic activity of neurons in the brain. This
results in a transient occurrence of signs which may be
characterized by short episodes with convulsions or focal
motor, autonomic or behavioural features and due to ab-
normal excessive and/or synchronous epileptic neuronal
activity in the brain.Reactive seizure
A reactive seizure is a seizure occurring as a natural re-
sponse from the normal brain to a transient disturbance
in function (metabolic or toxic in nature)—which is re-
versible when the cause or disturbance is rectified. A
provoked seizure can be considered as being synonym-
ous with a reactive seizure.
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Epilepsy is defined as a disease of the brain characterized
by an enduring predisposition to generate epileptic sei-
zures. This definition is usually practically applied as having
at least two unprovoked epileptic seizures >24 h apart [48].
Classification
Historically veterinary medicine has operated with vari-
ous terminology/synonyms for epilepsy types defined
by aetiology and phenotypic manifestations which are
themselves defined by the distribution of abnormal
electrical activity in the brain. The development of ILAE
classifications and changes in veterinary epilepsy termino-
logy throughout time are detailed in Table 1 and 2.
Epilepsy types defined by aetiology
Idiopathic epilepsy
Idiopathic epilepsy (idiopathic defined as a disease in
its own right, per se) should be seen as the overarching
and bridging term, which can be sub-classified into three
sub-groups reflecting the advancements in the field:
1. Idiopathic epilepsy (genetic epilepsy)—a causative
gene for epilepsy has been identified/confirmed
genetic background
2. Idiopathic epilepsy (suspected genetic epilepsy)—a
genetic influence supported by a high breed
prevalence (>2 %), genealogical analysis and/or
familial accumulation of epileptic individuals*,**.
*Shorvon stated in 2014 [5]: “It seems very likely that
the genetic influences in idiopathic epilepsies
probably are complex involving multiple genes and
interactions between genes (epistatic) and between
genes and the environment (epigenetic)”.
**A list of breeds with a high epilepsy incidence or
prevalence compared to the general background
population can be found in Hülsmeyer et al. [26].
Please note that the epilepsy status within breeds may
fluctuate over time and furthermore be influenced by
differences between countries (e.g. due to preferences
with respect to currently popular breeding lines).
3. Idiopathic epilepsy (epilepsy of unknown
cause)—epilepsy in which the nature of the
underlying cause is as yet unknown and with no
indication of structural epilepsy.
Please see consensus on Diagnostic approach to epilepsy in
dogs [49] for further information on diagnostic work-up.
Structural epilepsy
Structural epilepsy is characterized by epileptic seizures
which are provoked by intracranial/cerebral pathology
including vascular, inflammatory/infectious, traumatic,
anomalous/developmental, neoplastic and degenerativediseases confirmed by diagnostic imaging, cerebrospinal
fluid examination, DNA testing or post mortem findings
(see consensus on Diagnostic approach to epilepsy in
dogs [49]). Lafora disease progressive myoclonic epilepsy
would be classified under structural epilepsy as the gene
defect results in a storage disease which alters the brain
structurally and where the epileptic seizures associated
with the structural changes in the brain are one of the
multiple clinical and neurological signs associated with
the primary storage disease [50].
Classification by seizure semiology (seizure type
classification)
Focal epileptic seizures
Focal epileptic seizures are characterized by lateralized
and/or regional signs (motor, autonomic or behavioural
signs, alone or in combination). The ictal onset is consist-
ent from one epileptic seizure to another. They may be
discretely localised or more widely distributed. Focal epi-
leptic seizures may originate in subcortical structures, with
preferential propagation patterns that can involve the
contralateral hemisphere. With focal epileptic seizures, the
abnormal electrical activity arises in a localized group of
neurons or network within one hemisphere. The clinical
signs reflect the functions of the area or areas involved.
Focal epileptic seizures can present as:
 Motor (episodic focal motor phenomena e.g. facial
twitches, repeated jerking head movements,
rhythmic blinking, twitching of facial musculature or
repeated rhythmic jerks of one extremity)
 Autonomic (with parasympathetic and epigastric
components e.g. dilated pupils, hypersalivation or
vomiting)
 Behavioural (focal epileptic seizure activity which in
humans can represent psychic and/or sensory
seizure phenomena may in animals result in a short
lasting episodic change in behaviour such as e.g.
anxiousness, restlessnesss, unexplainable fear
reactions or abnormal attention seeking/‘clinging’ to
the owner.
Generalized epileptic seizures
Generalized epileptic seizures are characteried by bilateral
involvement (both sides of body and therefore both cere-
bral hemispheres involved). Generalized epileptic seizures
may occur alone or evolve from a focal epileptic seizure
start. In dogs and cats generalized epileptic seizures
predominantly present as tonic, clonic or tonic-clonic
epileptic seizures. As a rule the animal will lose
consciousness during convulsive epileptic seizures
(myoclonic seizures excluded). Salivation, urination and/
or defecation furthermore often also occur (myoclonic
seizures excluded).
Table 1 Veterinary terminology and its most common amendments over time
Early terminology Terminology currently in use Suggested veterinary terminology 2015
EPILEPTIC SEIZURES
An epileptic seizure with clinical signs indicating activity which
starts in a localised area in the brain
Petit Mal Partial/focal seizure Focal epileptic seizurea
Aura - Simple partial/focal seizure
(consciousness unimpaireda)-Will present with focal motor, autonomic or behavioural signs
alone or in combination - Complex partial/focal seizure
(consciousness impaireda)
An epileptic seizure with clinical signs indicating activity
involving both cerebral hemispheres from the start.
-In dogs and cats the seizure presents predominantly as immediate
‘convulsions’ and loss of consciousness. Salivation, urination
and/or defecation often also occur during convulsions.
May also (but rare) present as atonic or myoclonic seizures
Grand Mal (always implicating convulsions) Primary generalized seizure Generalized epileptic seizure
An epileptic seizure which starts in a localized area in the
brain and spreads subsequently to involve both hemispheres.
-In dogs and cats the seizure starts with localized motor,
autonomic and/or behavioural signs rapidly followed by
convulsions. Salivation, urination and/or defecation often
also occur during convulsions.
Partial seizure with secondary generalization
(secondary generalized seizure)
Focal seizure with secondary
generalization
Focal epileptic seizure evolving to become
generalized
EPILEPSY
Epilepsy classified by aetiology Primary Epilepsy Idiopathic Epilepsy Idiopathic Epilepsy
- Epilepsy where no structural cerebral
pathology is suspected
- Epilepsy where no structural cerebral
pathology is suspected. A genetic
component may be involved
1. Proven genetic background
2. Suspected genetic background
3. Unknown cause and no indication of
structural epilepsy
Epilepsy classified by aetiology Secondary or Acquired epilepsy Symptomatic Epilepsy Structural epilepsy
- Epilepsy caused by identified
cerebral pathology
- Epilepsy caused by identified
cerebral pathology
- Epilepsy caused by identified
cerebral pathology
Epilepsy classified by aetiology Cryptogenic Probably or possibly symptomatic
epilepsy
Unknown cause
- Meaning hidden - A suspected symptomatic cause, which
however remains obscure
aRegarding our ability to evaluate if consciousness is unimpaired or impaired during focal seizures (former termed simple and complex focal seizures). We recommend that it is not attempted to interpret signs












Table 2 Development of ILAE classifications
ILAE 1981 and 1989 ILAE 2010 Berg and Scheffer 2011 [28]
Generalized seizures are those in which the first
clinical and electroencephalographic changes
indicate initial involvement of both cerebral
hemispheres.
Generalized seizures are conceptualized as originating at some point within
and rapidly engaging bilaterally distributed networks. Such bilateral networks
can include cortical and subcortical structures, but do not necessarily include
the entire cortex.
Generalized seizures can be asymmetric.
Focal seizures (previously defined as partial)
are those in which the first clinical and
electroencephalographic changes indicate
initial activation of a system of neurons limited
to a part of one cerebral hemisphere.
Focal seizures are conceptualized as originating at some point within networks
limited to one hemisphere. They may be discretely localized or more widely
distributed. Focal seizures may originate in subcortical structures. For each
seizure type, ictal onset is consistent from one seizure to another, with
preferential propagation patterns that can involve the contralateral hemisphere.
The Glossary of Ictal Semiology [51] Provides an initial vocabulary which, while
in need of revision and expansion, is an example of the type of “dictionary”
needed for discussing seizure semiology. This not only allows but requires
greater precision in seizure description. Terms such as hypermotor, akinetic,
versive, hemiconvulsion, and retained responsiveness or awareness
communicate much more information about a patient’s seizure manifestations
than do the terms complex and simple partial.
Idiopathic epilepsy: there is no underlying cause
other than a possible hereditary predisposition.
Genetic epilepsy: the epilepsy is, as best as understood, the direct result of a
known or presumed genetic defect(s) in which seizures are the core symptom
of the disorder. This attribution must be supported by specific forms of evidence
(e.g. specific molecular genetic studies or family studies).
Genetic: The epilepsy is a direct result of a genetic cause.
Ideally, a gene and the mechanisms should be identified;
however, this term would also apply to electroclinical
syndromes for which twin or family segregation studies
reproducibly show clinical evidence of a genetic basis
(e.g., in the case of the genetic generalized epilepsies).
At this time, channelopathies are the best example of
genetic epilepsies. Ultimately, we expect causes of
epilepsies to be identified by the mechanisms involved (i.e.,
channelopathies, mitochondrial respiratory chaindefects, etc.).
Symptomatic epilepsy: this type of epilepsy is
the consequence of a known or suspected
disorder of the central nervous system.
Structural and metabolic epilepsy: this type of epilepsy is the secondary result
of a distinct structural or metabolic condition. These structural or metabolic
disorders may be of acquired or genetic origin (as is the case for malformations
of cortical development and certain metabolic disorders).
Structural-Metabolic: The epilepsy is the secondary result of a
separate structural or metabolic condition. Structural and
metabolic were combined to separate the concept from
genetic and also because the two are often inseparable.
Note that structural brain lesions, including many
malformations of cortical development, often have genetic
causes and most metabolic disorders are also of genetic
origin. The distinction between “genetic epilepsy” and
epilepsy due to a structural/metabolic cause is far from
perfect, but we anticipate more specific characterizations
of cause in the upcoming years.
Cryptogenic (probable symptomatic) epilepsy:
this refers to a disorder whose cause is hidden or
occult. Cryptogenic epilepsies are presumed to
be symptomatic.
Unknown epilepsy: the nature of the underlying cause is as yet unknown; it
may have a fundamental genetic basis (e.g., a previously unrecognized
channelopathy) or it may be the consequence of an unrecognized structural
or metabolic disorder not yet identified.
Unknown: Plain and direct, this label simply and accurately
indicates ignorance and that further investigation is needed
to identify the cause of the epilepsy. Unlike cryptogenic
(presumed symptomatic), it makes no presumptions and

















 Myoclonic (Jerking movements usually affecting
both sides of the body)
Non-convulsive generalized epileptic seizures
 Atonic (also called ‘drop attacks’—sudden and
general loss of muscle tone which usually cause the
animal to collapse)
Focal epileptic seizures evolving into generalized epileptic
seizures
Focal epileptic seizures can spread from initial regional
cerebral involvement to bilateral cerebral involvement.
The seizure will start with regional motor, autonomic
and/or behavioural signs and then rapidly be followed by
a convulsive stage with bilateral tonic, clonic or tonic-
clonic activity and loss of consciousness. This is the
most common seizure type observed in the dog. The
onset of the focal epileptic seizure is often very short
(seconds to minutes) after which follows the secondary
generalisation with convulsions. The focal epileptic seiz-
ure onset may be difficult to detect due to its brief na-
ture. When taking the seizure history, clients should be
interviewed thoroughly about what (or if something)
happens before convulsions (please see De Risio et al.
[49] for further information on diagnostic work-up).
The semiological description of an epileptic seizure
If classification is to be carried out according to seizure
type, it makes sense to have a systematic way of describ-
ing seizures. The evolution of the seizure over time is
what is important.
Phases associated with epileptic seizures
The epileptic seizure is classified as the ictus (seizure
activity)—followed by a postictal phase (where the nor-
mal brain function is restored). The ictus may consist of
a generalized epileptic seizure alone, a focal epileptic seiz-
ure alone, or a focal epileptic seizure which evolves into a
generalized seizure. In the postictal phase, the brain re-
stores its normal function. The postictal phase may be very
short or last for several hours to days. Typically, the animal
is disoriented, may have behavioural abnormalities such as
repetitive vocalisation, compulsive locomotion failing to
avoid obstacles, be tired, ataxic, hungry or thirsty, ex-
press a need to urinate, defecate or appear exhausted
and sleep for a longer period of time. Postictal blindness
or aggression may also be present.Prodrome
In some animals (but not so common), ictus may be pre-
ceded by a so-called prodrome, a long-term (hours to
days) change in disposition and indicator of forthcoming
seizures. Humans may experience days of, for example,
irritability, withdrawal or other emotional aberrations. In
dogs the most common prodromal signs described are
hours or days of restlessness, anxiousness, appear as be-
ing irritated (e.g. with uncharacteristic aggression to-
wards other pets), or attention-seeking behaviour which
is known to the owner as a long-term marker of a forth-
coming seizure episode. Prodromes (if present) can repre-
sent a potential important therapeutic window for pulse
therapy. Prodromal signs must be discriminated from focal
seizure signs. Prodromal signs are defined by their long
lasting nature whereas focal seizures which may display
similar signs when they occur alone or before generalized
convulsive seizures are very short (seconds to minutes).
Consciousness in focal epileptic seizures
Variable to no impairment of consciousness may appear
during focal seizures. However, we propose that no at-
tempt should be made to evaluate if consciousness is un-
impaired or impaired (previously described as simple or
complex focal (or partial) seizures respectively). Al-
though animals may appear as if consciousness is im-
paired during focal epileptic seizures (awake but being
confused, not recognizing the owner, not responding to
commands) we cannot assess this objectively. It will al-
ways be a subjective interpretation in animals that can-
not report what they are experiencing. Therefore it is
not meaningful to subclassify focal epileptic seizures
using consciousness.
Agreed modified glossary of descriptive terminology for
ictal semiology in accordance with the ILAE guidelines
(based on Blume et al. [51])
The glossary of descriptive terminology was discussed
within the IVETF in 2014. The terms that the majority
of the group (>50 % of 95%CI from 14 raters) felt could
be also used to describe ictal semiology are listed below:
I. General terms
1.0 Semiology That branch of linguistics concerned
with clinical signs.
2.0 Epileptic seizure Manifestation(s) of excessive
synchronous, usually self-limiting epileptic activity
of neurons in the brain. This results in a transient
occurrence of signs which may be characterized by
short episodes with convulsions or focal motor,
autonomic or behavioural features and due to
abnormal excessive or synchronous epileptic
neuronal activity in the brain.
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a stroke or an epileptic seizure.
4.0 Epilepsy Epilepsy is defined as a disease of
the brain characterized by an enduring
predisposition to generate epileptic seizures. This
definition is usually practically applied as having
at least two unprovoked epileptic seizures >24 h
apart [48].
5.0 Focal epileptic seizures are conceptualized as
originating within networks limited to one
hemisphere. They may be discretely localized or
more widely distributed. Focal epileptic seizures may
originate in subcortical structures. For each epileptic
seizure type, ictal onset is consistent from one seizure
to another, with preferential propagation patterns that
can involve the contralateral hemisphere [27].
6.0 Generalised epileptic seizure An epileptic seizure
whose initial semiology indicates, or is consistent
with, more than minimal involvement of both
cerebral hemispheres. Generalized epileptic seizures
are conceptualized as originating at some point
within, and rapidly engaging, bilaterally distributed
networks [27].
7.0 Convulsion Primarily a lay term. Episodes of
excessive, abnormal muscle contractions, usually
bilateral, which may be sustained or interrupted.
II. Terms describing epileptic seizure semiology
These are descriptors of seizures unless specified otherwise.
1.0 Motor Involves skeletal musculature resulting in
any phenotypic manifestation. The motor event
could consist of an increase (positive) or decrease
(negative) in muscle contraction to produce a
movement. Unless noted, the following terms are
adjectives modifying “motor seizure” or “seizure”
e.g. “tonic motor seizure or dystonic seizure”, and
whose definitions can usually be understood as
prefaced by: “refers to …”.
1.1.1 Tonic A sustained increase in muscle
contraction lasting a few seconds to minutes.
1.1.1.2.1 Versive A sustained, forced conjugate
ocular, cephalic and/or truncal rotation
or lateral deviation from the midline.
1.1.1.2.2 Dystonic Sustained contractions of
both agonist and antagonist muscles
producing athetoid or twisting
movements which when prolonged
may produce abnormal postures.
1.1.2Myoclonic (adjective); Myoclonus (noun)
Sudden, brief (<100 msec) involuntary single
or multiple contraction(s) of muscles(s) or
muscle groups of variable topography (axial,
proximal limb, distal).1.1.2.1Clonic Myoclonus which is regularly
repetitive, involves the same muscle
groups, at a frequency of about 2–3
seconds, and is prolonged. Synonym:
rhythmic myoclonus.
1.1.3 Tonic-clonic A sequence consisting of a tonic
followed by a clonic phase. Variants such as
clonic-tonic-clonic may be seen.
1.1.3.1Generalised tonic-clonic epileptic seizure
(Formerly "Grand Mal" Seizure) Noun:
Bilateral symmetrical tonic contraction then
bilateral clonic contractions of somatic
muscles usually associated with autonomic
phenomena.
1.1.4Atonic Sudden loss or diminution of muscle
tone without an apparent preceding myoclonic
or tonic event lasting one to two seconds or
more, involving head, trunk, jaw or limb
musculature.
1.1.5 Synchronous (Asynchronous) Motor events
occurring (not) at the same time or at the
same rate in sets of body parts.1.2 Automatism Noun: A more or less coordinated,
repetitive, motor activity usually occurring when
cognition is impaired and for which the subject is
usually amnesic afterwards. This often resembles a
voluntary movement, and may consist of
inappropriate continuation of ongoing preictal motor
activity.
The following adjectives are usually employed to
modify “automatism”.
1.2.1Oroalimentary Lip smacking, lip pursing,
chewing, licking, teeth grinding or swallowing.
1.2.2 Pedal Indicates principally distal component
involvement, bilateral or unilateral. Usually
running movement.2.0 Non-motor
2.1 Aura* Noun: A ‘subjective’ ictal phenomenon that, in
a given patient, may precede an observable seizure; if
alone, constitutes a sensory seizure. This can result in
behavioral changes such as fear, aggression, searching
behaviour, attention, body sensation.
*What is an aura? Commonly owners report that they
can foresee a motor seizure when specific, and to the
owner, well known signs repeatedly appear within seconds
or minutes prior to convulsions. The term aura has in the
past been used to describe such a forewarning of convul-
sions. This term originated from human epileptology
where aura in early ILAE classifications was used “to de-
note symptomatology that encompasses subjective sensory
phenomena as well as vegetative signs (for example, the
epigastric sensations accompanying mesial temporal epi-
lepsy)” and thus did not include motor phenomena. The
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erinary medicine. The signs occurring as the first indica-
tion of seizure activity (marking the beginning of ictus)
and interpreted by the dog owner as a warning sign is in-
deed a focal seizure onset and should be referred to as
such.
2.2 Autonomic A sensation consistent with
involvement of the autonomic nervous system,
including cardiovascular, gastrointestinal, sudomotor,
vasomotor and thermoregulatory functions. In
companion animals, salivation, mydriasis, urination
and/or defecation may commonly be observed.
3.0 Somatotopic modifiers
3.1 Laterality3.1.1 Unilateral Exclusive or virtually exclusive
involvement of one side as a motor, sensory or
autonomic phenomenon.
3.1.1.1HEMI- A prefix to other descriptors e.g.
hemiclonic.
3.1.2 Generalised (syn. “bilateral”) More than
minimal involvement of each side as a motor
or autonomic phenomenon.
Motor component: further modified as:
3.1.2.1Asymmetrical Clear distinction in
quantity and/or distribution of activity on
the two sides.
3.1.2.2 Symmetrical Virtual bilateral equality in
these respects.3.2 Body part Refers to area involved i.e. limb, face,
trunk and other.
3.2.1 Axial Involves trunk, including neck.
3.2.2 Proximal limb Signifies involvement from
shoulders to metacarpus, hip to metatarsus.
3.2.3 Distal limb Indicates involvement of paws.4.0 Modifiers and descriptors of epileptic seizure
timing The following terms are listed in the form
(adjective, noun, verb) according to principal usage;
as adjective unless specified.
4.1 Incidence Noun: Refers to the number of epileptic
seizures within a time period or the number of
seizure days per unit of time.
4.1.1 Regular, irregular Consistent (inconsistent)
or predictable (unpredictable, chaotic)
intervals between such events.
4.1.2 Cluster Incidence of epileptic seizures within
a given period (usually one or a few days)
which exceeds the average of incidence over a
longer period for the patient. Cluster seizures
can be defined clinically as two or more
seizures within a 24-h period.
4.1.3 Provocative factor Noun: Transient and
sporadic endogenous or exogenous elementcapable of augmenting seizure incidence in the
patient with chronic epilepsy and evoking
seizures in susceptible non-epileptic
individuals.
4.1.3.1Reactive A reactive seizure is a seizure
occurring as a natural response from the
normal brain to a transient disturbance in
function (metabolic or toxic in
nature)—which is reversible when the
cause or disturbance is rectified. A
provoked seizure can be considered as
being synonymous with a reactive seizure.
4.1.3.2Reflex Objectively and consistently
demonstrated to be evoked by a specific
afferent stimulus or by activity of the
patient. Afferent stimuli can be:
elementary, i.e. unstructured (light flashes,
startle, a monotone sound) or elaborate i.e.
structured, (a symphony). Activity may be
elementary, e.g. motor (a movement).5.0 Duration Time between the beginning of initial
epileptic seizure manifestations, such as the e.g.,
focal epileptic seizure signs or full body convulsions
to the cessation of experienced or observed epileptic
seizure activity. Does not include non-specific seizure
premonitions or postictal states.
5.1 Status epilepticus An epileptic seizure which shows
no clinical signs of arresting after a duration
encompassing the great majority of seizures of that
type in most patients or recurrent epileptic seizures
without resumption of baseline central nervous system
function interictally. Status epilepticus can be defined
clinically as (a) greater than 5 min of continuous
epileptic seizures or (b) two or more discrete epileptic
seizures between which there is incomplete recovery of
consciousness (for generalized convulsive seizures).
6.0 Severity A multicomponent assessment of an
epileptic seizure by observers and the patient.
Components primarily of observer assessment include:
duration, extent of motor involvement, impairment of
interaction with environment intra-ictally, maximum
number of seizures per unit of time.
7.0 Prodrome A pre-ictal phenomenon. A subjective or
objective clinical alteration that heralds the onset of
an epileptic seizure but does not form part of it.
Prodrome is a long lasting event (hours to days) and
should not be confused with focal onset seizure signs
which are very brief events (seconds to minutes).
8.0 Postictal phenomenon A transient clinical
abnormality of central nervous system function that
appears or becomes accentuated when clinical signs
of the ictus have ended.
Berendt et al. BMC Veterinary Research  (2015) 11:182 Page 10 of 118.1 Lateralising (TODD‘S (or bravais’))
phenomenon Any unilateral postictal dysfunction
relating to motor, somatosensory and/or integrative
functions including visual, auditory or
somatosensory.
8.1 Non-lateralising phenomenon Behavioural
changes such as fear, aggression, increased appetite.
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